- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6827 - Hybridisation assays for detection of mutation or polymorphism
Patent holdings for IPC class C12Q 1/6827
Total number of patents in this class: 2478
10-year publication summary
85
|
93
|
224
|
329
|
334
|
304
|
263
|
285
|
275
|
151
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Natera, Inc. | 320 |
58 |
Guardant Health, Inc. | 415 |
48 |
10X Genomics, Inc. | 1202 |
46 |
Illumina, Inc. | 3340 |
40 |
Bio-Rad Laboratories, Inc. | 1615 |
36 |
The Chinese University of Hong Kong | 153 |
34 |
Foundation Medicine, Inc. | 360 |
30 |
Regeneron Pharmaceuticals, Inc. | 4252 |
29 |
The Regents of the University of California | 19887 |
26 |
Massachusetts Institute of Technology | 10041 |
25 |
The Johns Hopkins University | 5662 |
25 |
The Broad Institute, Inc. | 1800 |
25 |
Children's Medical Center Corporation | 1865 |
25 |
Exact Sciences Corporation | 296 |
22 |
President and Fellows of Harvard College | 5972 |
20 |
The Board of Trustees of the Leland Stanford Junior University | 6403 |
18 |
Pacific Biosciences of California, Inc. | 760 |
18 |
Affymetrix, Inc. | 260 |
17 |
Roche Molecular Systems, Inc. | 923 |
17 |
F. Hoffmann-La Roche AG | 7930 |
16 |
Other owners | 1903 |